Testosterone and adipokines are determinants of physical performance, strength, and aerobic fitness in frail, obese, older adults

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Aguirre, Lina E ^a,b   Jan, Irum Zeb ^a   Fowler, Kenneth ^a,b   Waters, Debra L ^c,d   Villareal, Dennis T ^a,d   Armamento Villareal, Reina ^a,d  

^a NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^b New Mexico Engineering Research Inst   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; ESTRADIOL; INSULIN GROWTH FACTOR 1; INTERLEUKIN 6; LEPTIN; SOMATOMEDIN; TESTOSTERONE; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

AEROBIC EXERCISE; AGED; ARTICLE; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; FEMALE; FITNESS; FRAIL ELDERLY; HORMONE BLOOD LEVEL; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE EXTENSION; KNEE FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; OBESITY; ONE REPETITION MAXIMUM; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY, CAPACITY AND PERFORMANCE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

EID: 84934944742     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/507395     Document Type: Article

References (44)

1. G. L. Jensen and P. Y. Hsiao, "Obesity in older adults: Relationship to functional limitation," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 1, pp. 46-51, 2010.
2. C. A. Zizza, A. Herring, J. Stevens, and B. M. Popkin, "Obesity affects nursing-care facility admission among whites but not blacks," Obesity Research, vol. 10, no. 8, pp. 816-823, 2002.
3. D. T. Villareal, M. Banks, C. Siener, D. R. Sinacore, and S. Klein, "Physical frailty and body composition in obese elderly men and women," Obesity Research, vol. 12, no. 6, pp. 913-920, 2004.
4. S. Basaria, A. D. Coviello, T. G. Travison et al., "Adverse events associated with testosterone administration," The New England Journal of Medicine, vol. 363, no. 2, pp. 109-122, 2010.
5. T. G. Travison, S. Basaria, T. W. Storer et al., "Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation," Journals of Gerontology A Biological Sciences and Medical Sciences, vol. 66, no. 10, pp. 1090-1099, 2011.
6. N.M. Appelman-Dijkstra, K.M. J. A. Claessen, F. Roelfsema, A. M. Pereira, and N. R. Biermasz, "Long-term effects of recombinant human GH replacement in adults with GH deficiency: A systematic review," European Journal of Endocrinology, vol. 169, no. 1, pp. R1-R14, 2013.
7. F. De Benedetti, T. Alonzi, A. Moretta et al., "Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation," Journal of Clinical Investigation, vol. 99, no. 4, pp. 643-650, 1997.
8. D. T. Villareal, S. Chode, N. Parimi et al., "Weight loss, exercise, or both and physical function in obese older adults," The New England Journal ofMedicine, vol. 364, no. 13, pp. 1218-1229, 2011.
9. D. T. Villareal,M. Banks,D.R. Sinacore, C. Siener, and S. Klein, "Effect of weight loss and exercise on frailty in obese older adults," Archives of Internal Medicine, vol. 166, no. 8, pp. 860-866, 2006.
10. D. T. Villareal and J. O. Holloszy, "DHEA enhances effects of weight training on muscle mass and strength in elderly women and men,"The American Journal of Physiology-Endocrinology and Metabolism, vol. 291, no. 5, pp. E1003-E1008, 2006.
11. E. P.Weiss, S. B. Racette, D. T. Villareal et al., "Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss," Journal of Applied Physiology, vol. 102, no. 2, pp. 634-640, 2007.
12. S. Bhasin, G. R. Cunningham, F. J. Hayes et al., "Testosterone therapy in men with androgen deficiency syndromes: An endocrine society clinical practice guideline," Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2536-2559, 2010.
13. M. A. Saafi, D. Frere-Meunier, L. Feasson, N. Boutahar, and C. Denis, "Physical fitness is independently related to blood Leptin concentration and insulin sensitivity index in male subjects with central adiposity," Obesity Facts, vol. 5, no. 1, pp. 91-103, 2012.
14. R. Roubenoff, "Sarcopenia: Effects on body composition and function," Journals of Gerontology A Biological Sciences and Medical Sciences, vol. 58, no. 11, pp. 1012-1017, 2003.
15. M. Cesari, S. B. Kritchevsky, R. N. Baumgartner et al., "Sarcopenia, obesity, and inflammation-results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study," The American Journal of Clinical Nutrition, vol. 82, no. 2, pp. 428-434, 2005.
16. M. Saghizadeh, J. M. Ong, W. T. Garvey, R. R.Henry, and P. A. Kern, "The expression of TNF by humanmuscle: Relationship to insulin resistance," Journal of Clinical Investigation, vol. 97,no. 4, pp. 1111-1116, 1996.
17. A. R. Cappola, Q. L. Xue, L. Ferrucci, J.M. Guralnik, S. Volpato, and L. P. Fried, "Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women," Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 5, pp. 2019-2025, 2003.
18. V. Messier, R. Rabasa-Lhoret, S. Barbat-Artigas, B. Elisha, A. D. Karelis, and M. Aubertin-Leheudre, "Menopause and sarcopenia: A potential role for sex hormones," Maturitas, vol. 68, no. 4, pp. 331-336, 2011.
19. H. A. Feldman, C. Longcope, C. A. Derby et al., "Age trends in the level of serum testosterone and other hormones in middleaged men: Longitudinal results from the Massachusetts Male Aging Study," Journal of Clinical Endocrinology andMetabolism, vol. 87, no. 2, pp. 589-598, 2002.
20. S. M. Harman, E. J. Metter, J. D. Tobin, J. Pearson, and M. R. Blackman, "Longitudinal effects of aging on serum total and free testosterone levels in healthy men," Journal of Clinical Endocrinology andMetabolism, vol. 86, no. 2, pp. 724-731, 2001.
21. S. Khosla, L. J. Melton III, E. J. Atkinson, and W. M. O'Fallon, "Relationship of serumsex steroid levels to longitudinal changes in bone density in young versus elderlymen," Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3555-3561, 2001.
22. N. Bassil, S. Alkaade, and J. E. Morley, "The benefits and risks of testosterone replacement therapy: A review," Therapeutics and Clinical Risk Management, vol. 5, no. 1, pp. 427-448, 2009.
23. P. J. Snyder, H. Peachey, P. Hannoush et al., "Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age," Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 8, pp. 2647-2653, 1999.
24. A. M. Kenny, K. M. Prestwood, C. A. Gruman, K. M. Marcello, and L. G. Raisz, "Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels," Journals of Gerontology A Biological Sciences andMedical Sciences, vol. 56, no. 5, pp.M266-M272, 2001.
25. S. T. Page, J. K. Amory, F. D. Bowman et al., "Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T," Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1502-1510, 2005.
26. S. Basaria, A. D. Coviello, T. G. Travison et al., "Adverse events associated with testosterone administration,"NewEngland Journal of Medicine, vol. 363, no. 2, pp. 109-122, 2010.
27. U. Srinivas-Shankar, S. A. Roberts, M. J. Connolly et al., "Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: A randomized, double-blind, placebo-controlled study," Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 639-650, 2010.
28. K. J. Ottenbacher, M. E. Ottenbacher, A. J. Ottenbacher, A. A. Acha, and G.V. Ostir, "Androgen treatment andmuscle strength in elderly men: A meta-analysis," Journal of the American Geriatrics Society, vol. 54, no. 11, pp. 1666-1673, 2006.
29. J. L. Shifren, G. D. Braunstein, J. A. Simon et al., "Transdermal testosterone treatment inwomen with impaired sexual function after oophorectomy,"The New England Journal ofMedicine, vol. 343, no. 10, pp. 682-688, 2000.
30. S. R. Davis, M. Moreau, R. Kroll et al., "Testosterone for low libido in postmenopausal women not taking estrogen," The New England Journal of Medicine, vol. 359, no. 19, pp. 2005-2017, 2008.
31. J. L. Shifren, S. R. Davis, M. Moreau et al., "Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study," Menopause, vol. 13, no. 5, pp. 770-779, 2006.
32. G. Huang, S. Basaria, T. G. Travison et al., "Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: Effects on sexual function, body composition, muscle performance and physical function in a randomized trial," Menopause, vol. 21, no. 6, pp. 612-623, 2014.
33. G. I. Smith, J. Yoshino, D. N. Reeds et al., "Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women," The Journal of Clinical Endocrinology andMetabolism, vol. 99, no. 1, pp. 256-265, 2014.
34. D. J. Dyck, "Adipokines as regulators of muscle metabolism and insulin sensitivity," Applied Physiology, Nutrition and Metabolism, vol. 34, no. 3, pp. 396-402, 2009.
35. G. R. Steinberg, A. Bonen, and D. J. Dyck, "Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats," The American Journal of Physiology- Endocrinology and Metabolism, vol. 282, no. 3, pp. E593-E600, 2002.
36. D. M. Muoio, G. Lynis Dohn, F. T. Fiedorek Jr., E. B. Tapscott, and R. A. Coleman, "Leptin directly alters lipid partitioning in skeletal muscle," Diabetes, vol. 46, no. 8, pp. 1360-1363, 1997.
37. B. Antony, G. Jones, O. Stannus, L. Blizzard, and C. Ding, "Body fat predicts an increase and limbmuscle strength predicts a decrease in leptin in older adults over 2. 6 years," Clinical Endocrinology, vol. 79, no. 5, pp. 652-660, 2013.
38. G. R. Steinberg and D. J. Dyck, "Development of leptin resistance in rat soleus muscle in response to high-fat diets," The American Journal of Physiology-Endocrinology and Metabolism, vol. 279, no. 6, pp. E1374-E1382, 2000.
39. G. R. Steinberg, M. L. Parolin, G. J. F. Heigenhauser, and D. J. Dyck, "Leptin increases FA oxidation in lean but not obese human skeletal muscle: Evidence of peripheral leptin resistance," The American Journal of Physiology-Endocrinology and Metabolism, vol. 283, no. 1, pp. E187-E192, 2002.
40. T. Yamauchi, J. Kamon, Y. Minokoshi et al., "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase," Nature Medicine, vol. 8, no. 11, pp. 1288-1295, 2002.
41. E. Tomas, T.-S. Tsao, A. K. Saha et al., "Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16309-16313, 2002.
42. K. L. Mullen, A. C. Smith, K. A. Junkin, and D. J. Dyck, "Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats," The American Journal of Physiology- Endocrinology and Metabolism, vol. 293, no. 1, pp. E83-E90, 2007.
43. G. Loncar, B. Bozic, H. S. von et al., "Association of adiponectin with peripheral muscle status in elderly patients with heart failure," European Journal of InternalMedicine, vol. 24, no. 8, pp. 818-823, 2013.
44. L. Bucci, S. L. Yani, C. Fabbri et al., "Circulating levels of adipokines and IGF-1 are associated with skeletal muscle strength of young and old healthy subjects," Biogerontology, vol. 14, no. 3, pp. 261-272, 2013.